ijms-logo

Journal Browser

Journal Browser

Molecular Mechanisms, Emerging Biomarkers, Novel Therapies and Personalized Treatment in Celiac Disease (CD)

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Immunology".

Deadline for manuscript submissions: 28 February 2025 | Viewed by 89

Special Issue Editor


E-Mail Website
Guest Editor
Department of Experimental Biology, Faculty of Health Sciences, University of Jaén, 23071 Jaén, Spain
Interests: celiac disease; intestinal organoids; extracellular microvesicles in liquid biopsy; immune checkpoints
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues, 

Understanding the molecular mechanisms of CD, coupled with the development of new biomarkers and therapies, are contributting for more effective and personalized management of the disease. Advances in research continue to hold promise for improving the quality of life for individuals affected by celiac disease. Emerging biomarkers are being developed to improve the diagnosis and management of CD. These include deamidated gliadin peptides (DGPs), cytokine profiles, microRNAs, and markers of intestinal permeability. Microbial biomarkers and specific proteins found in blood and stool are also being explored for their potential to enhance diagnostic accuracy and monitor disease activity. In terms of novel therapies, there is ongoing research aimed at developing treatments that go beyond the traditional gluten-free diet (GFD). Some strategies include enzyme therapies to break down gluten, gluten-sequestering agents, inhibitors of TG2 to prevent the immune response, and therapies to modulate intestinal permeability and the gut microbiome. Additionally, nanoparticle-based delivery systems and genetic and cell-based therapies, such as gene editing and adoptive cell transfer, are being investigated for their potential to offer more personalized and effective treatment options. These advancements hold promise for improving the quality of life for individuals with CD by providing more precise diagnostic tools, better monitoring capabilities, and potentially curative treatments.

Thus, this Special Issue entitled ‘Molecular Mechanisms, Emerging Biomarkers, Novel Therapies and Personalized Treatment in Celiac Disease (CD) will explores recent advancements in understanding and managing CD.

Dr. María Isabel Torres
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • celiac disease
  • gluten sensitivity
  • immune response
  • emerging biomarkers
  • novel therapies
  • microbiome modulation
  • personalized treatment

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop